Prospective Study To Assess The Safety And Effectiveness Of Tixel Treatment On Dry Eye Symptoms In Asian Patients (DED)
A Prospective Study Assessing The Impact Of Tixel Treatment On Dry Eye Symptoms And Signs In Asian Patients With Dry Eye
Sponsor: Novoxel Ltd.
Terminated
Due to COVID19 adequate study monitoring wasn't possible by the Sponsor
Other terminated trials from Novoxel Ltd.
More terminations from Novoxel Ltd.
Listed as NCT04260893, this NA trial focuses on Dry Eye and Dry Eye Syndromes and remains terminated or withdrawn. Sponsored by Novoxel Ltd., it has been updated 7 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jun 2021 — Jul 2024 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Jan 2021 — Jun 2021 [monthly]
Recruiting NA
-
Oct 2020 — Jan 2021 [monthly]
Recruiting NA
▶ Show 2 earlier versions
-
Jun 2020 — Oct 2020 [monthly]
Recruiting NA
-
Mar 2020 — Jun 2020 [monthly]
Recruiting NA
First recorded
Jan 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Novoxel Ltd.
For direct contact, visit the study record on ClinicalTrials.gov .